Several recent papers have investigated the signaling pathways activated in lupus BMSC and have identified several “druggable targets” including mTOR [47], JAK-STAT [48], and the Wnt/β-catenin pathway [49]. Here, MTOR is linked to systemic lupus erythematosus.